428 related articles for article (PubMed ID: 18249024)
1. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
[TBL] [Abstract][Full Text] [Related]
2. Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis.
Piccinni MP; Vultaggio A; Scaletti C; Livi C; Gomez MJ; Giudizi MG; Biagiotti R; Cassone A; Romagnani S; Maggi E
J Infect Dis; 2002 Jul; 186(1):87-93. PubMed ID: 12089666
[TBL] [Abstract][Full Text] [Related]
3. Immunity to Candida.
Fidel PL
Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
[TBL] [Abstract][Full Text] [Related]
4. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.
Leigh JE; Steele C; Wormley FL; Luo W; Clark RA; Gallaher W; Fidel PL
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):373-80. PubMed ID: 9833746
[TBL] [Abstract][Full Text] [Related]
5. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.
Drobacheff C; Millon L; Monod M; Piarroux R; Robinet E; Laurent R; Meillet D
Clin Chem Lab Med; 2001 Jun; 39(6):519-26. PubMed ID: 11506465
[TBL] [Abstract][Full Text] [Related]
6. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.
Leigh JE; Barousse M; Swoboda RK; Myers T; Hager S; Wolf NA; Cutright JL; Thompson J; Sobel JD; Fidel PL
J Infect Dis; 2001 Jan; 183(2):277-285. PubMed ID: 11120933
[TBL] [Abstract][Full Text] [Related]
7. Altered CD4+ T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1.
Lewandowski D; Marquis M; Aumont F; Lussier-Morin AC; Raymond M; Sénéchal S; Hanna Z; Jolicoeur P; de Repentigny L
J Immunol; 2006 Jul; 177(1):479-91. PubMed ID: 16785545
[TBL] [Abstract][Full Text] [Related]
8. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis.
Tardif F; Goulet JP; Zakrazewski A; Chauvin P; Rouabhia M
Med Sci Monit; 2004 Aug; 10(8):BR239-49. PubMed ID: 15277983
[TBL] [Abstract][Full Text] [Related]
9. Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.
Fidel PL
Adv Dent Res; 2006 Apr; 19(1):80-4. PubMed ID: 16672555
[TBL] [Abstract][Full Text] [Related]
10. Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.
Goupil M; Cousineau-Côté V; Aumont F; Sénéchal S; Gaboury L; Hanna Z; Jolicoeur P; de Repentigny L
BMC Immunol; 2014 Oct; 15():49. PubMed ID: 25344377
[TBL] [Abstract][Full Text] [Related]
11. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
[TBL] [Abstract][Full Text] [Related]
12. Oral keratinocyte immune responses in HIV-associated candidiasis.
Eversole LR; Reichart PA; Ficarra G; Schmidt-Westhausen A; Romagnoli P; Pimpinelli N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):372-80. PubMed ID: 9347501
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients.
Millon L; Drobacheff C; Piarroux R; Monod M; Reboux G; Laurent R; Meillet D
J Acquir Immune Defic Syndr; 2001 Feb; 26(2):137-44. PubMed ID: 11242180
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.
Farah CS; Hu Y; Riminton S; Ashman RB
Oral Microbiol Immunol; 2006 Aug; 21(4):252-5. PubMed ID: 16842510
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis.
Yadev NP; Murdoch C; Saville SP; Thornhill MH
Microb Pathog; 2011 Jun; 50(6):278-85. PubMed ID: 21296654
[TBL] [Abstract][Full Text] [Related]
16. Oral mucosal cell response to Candida albicans in transgenic mice expressing HIV-1.
de Repentigny L; Lewandowski D; Aumont F; Hanna Z; Jolicoeur P
Methods Mol Biol; 2009; 470():359-68. PubMed ID: 19089395
[TBL] [Abstract][Full Text] [Related]
17. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy.
Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y
Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928
[TBL] [Abstract][Full Text] [Related]
19. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
[TBL] [Abstract][Full Text] [Related]
20. Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis.
Schaller M; Boeld U; Oberbauer S; Hamm G; Hube B; Korting HC
Microbiology (Reading); 2004 Sep; 150(Pt 9):2807-2813. PubMed ID: 15347740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
